Regeneron Pharmaceuticals Stock Price

0.00 (0.0%)
Upgrade to Real-Time
Afterhours (Closed)
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
Small Cap Basic
Monthly Subscription
for only
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Regeneron Pharmaceuticals Inc REGN NASDAQ Common Stock
  Price Change Change Percent Stock Price Low Price High Price Open Price Close Price Last Traded
0.00 0.0% 640.63 0.00 0.00 0.00 640.63 20:00:00
Bid Price Ask Price Spread Spread % News
635.50 640.63 5.13 0.8% - -
Last Trade Time Type Quantity Stock Price Currency
- 0 $ 640.63 USD

Regeneron Pharmaceuticals Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 65.73B 102.60M 100.79M $ 7.86B $ 2.70B 18.45 30.60
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - -

more financials information »

Regeneron Pharmaceuticals News

Date Time Source News Article
7/08/202016:30PR Newswire (US)Regeneron to Report Second Quarter 2020 Financial and..
7/08/202016:23Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)
7/08/202016:20Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)
7/07/202012:30Dow Jones NewsU.S. Commits $2 Billion for Covid-19 Vaccine, Drug Supplies..
7/07/202010:59Dow Jones NewsU.S. Commits $2 Billion for Covid-19 Vaccine, Drug Supplies
7/07/202007:44Dow Jones NewsRegeneron Gets Federal Manufacturing Contract for Covid-19..
7/07/202007:29Edgar (US Regulatory)Current Report Filing (8-k)
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical REGN Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week635.00655.9255623.50637.271,014,8965.630.89%
1 Month616.01655.9255575.89619.901,001,22024.624.0%
3 Months549.99655.9255507.69583.321,370,53090.6416.48%
6 Months384.62655.9255328.125509.721,323,896256.0166.56%
1 Year308.15655.9255271.37441.721,013,731332.48107.9%
3 Years497.61655.9255271.37400.67860,668143.0228.74%
5 Years514.50655.9255271.37411.74849,789126.1324.52%

Regeneron Pharmaceuticals Description

Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation. The company has six marketed products: Eylea, approved for wet age-related macular degeneration and other eye diseases; Praluent for LDL cholesterol lowering; Zaltrap in colorectal cancer; Dupixent in atopic dermatitis, asthma, and nasal polyposis; Libtayo in cutaneous squamous cell carcinoma; Arcalyst in CAPS; and Kevzara in rheumatoid arthritis. Regeneron is also developing monoclonal antibodies with Sanofi in immunology and cancer.
Your Recent History
Regeneron ..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20200710 07:14:45